Allianz Asset Management GmbH purchased a new position in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 5,600 shares of the business services provider's stock, valued at approximately $454,000.
A number of other large investors have also recently made changes to their positions in EXPO. Bank of Montreal Can boosted its position in Exponent by 1.5% in the 4th quarter. Bank of Montreal Can now owns 8,747 shares of the business services provider's stock valued at $779,000 after buying an additional 131 shares during the period. State of Alaska Department of Revenue raised its holdings in shares of Exponent by 2.7% in the 1st quarter. State of Alaska Department of Revenue now owns 5,946 shares of the business services provider's stock valued at $481,000 after purchasing an additional 155 shares in the last quarter. CIBC Private Wealth Group LLC raised its holdings in shares of Exponent by 3.8% in the 4th quarter. CIBC Private Wealth Group LLC now owns 4,418 shares of the business services provider's stock valued at $394,000 after purchasing an additional 161 shares in the last quarter. Mitchell & Pahl Private Wealth LLC raised its holdings in shares of Exponent by 2.5% in the 1st quarter. Mitchell & Pahl Private Wealth LLC now owns 6,709 shares of the business services provider's stock valued at $544,000 after purchasing an additional 164 shares in the last quarter. Finally, Portside Wealth Group LLC raised its holdings in shares of Exponent by 6.0% in the 1st quarter. Portside Wealth Group LLC now owns 2,993 shares of the business services provider's stock valued at $243,000 after purchasing an additional 170 shares in the last quarter. 92.37% of the stock is owned by hedge funds and other institutional investors.
Exponent Stock Performance
NASDAQ:EXPO opened at $68.33 on Friday. Exponent, Inc. has a one year low of $63.81 and a one year high of $115.75. The firm has a market cap of $3.47 billion, a P/E ratio of 34.17 and a beta of 0.89. The firm has a 50-day simple moving average of $74.71 and a 200-day simple moving average of $80.24.
Exponent (NASDAQ:EXPO - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The business services provider reported $0.52 EPS for the quarter, beating the consensus estimate of $0.48 by $0.04. Exponent had a net margin of 18.35% and a return on equity of 24.24%. The business had revenue of $132.87 million during the quarter, compared to analyst estimates of $130.82 million. During the same quarter in the previous year, the business posted $0.57 EPS. The company's quarterly revenue was up 7.3% compared to the same quarter last year. On average, research analysts predict that Exponent, Inc. will post 1.98 EPS for the current fiscal year.
Exponent Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 19th. Investors of record on Friday, September 5th will be paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.8%. The ex-dividend date is Friday, September 5th. Exponent's payout ratio is 60.00%.
Insider Buying and Selling
In related news, VP Joseph Rakow sold 1,573 shares of the business's stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $77.72, for a total transaction of $122,253.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP John Pye sold 2,000 shares of the business's stock in a transaction that occurred on Friday, May 23rd. The stock was sold at an average price of $76.32, for a total transaction of $152,640.00. Following the transaction, the vice president owned 29,204 shares of the company's stock, valued at approximately $2,228,849.28. This trade represents a 6.41% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 6,267 shares of company stock worth $489,120 in the last 90 days. 1.60% of the stock is owned by corporate insiders.
Exponent Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Further Reading
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.